FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Srilatha Edupuganti

Research Profile

Chemicals & Drugs

Physiology

Living Beings

Disorders

Concepts & Ideas

Molecular Sequence Data

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Srilatha Edupuganti; Rachel Barwick Eidex; Harry L Keyserling; Robert S Lanciotti; Harvey B Lipman; Mark MULLIGAN; Walter Orenstein; Yi Pan; Troy D Querec; Dirk Teuwen; Rafi Ahmed; Rama S Akondy; Alan Barrett; Martin S Cetron; Carlos del Rio
A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity.
Jennifer A Whitaker; Nadine G Rouphael; Srilatha Edupuganti; Lilin Lai; Mark MULLIGAN
Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1.
Katherine Gibney; Olga I Kosoy; Robert S Lanciotti; Mark MULLIGAN; Amanda J Panella; Mark J Delorey; Srilatha Edupuganti; Marc Fischer; J Erin Staples
Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Srilatha Edupuganti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Srilatha Edupuganti; Rachel Barwick Eidex; Harry L Keyserling; Robert S Lanciotti; Harvey B Lipman; Mark MULLIGAN; Walter Orenstein; Yi Pan; Troy D Querec; Dirk Teuwen; Rafi Ahmed; Rama S Akondy; Alan Barrett; Martin S Cetron; Carlos del Rio
A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity.
The American journal of tropical medicine and hygiene 2013;88(1):172-7.
2012: Jennifer A Whitaker; Nadine G Rouphael; Srilatha Edupuganti; Lilin Lai; Mark MULLIGAN
Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1.
The Lancet infectious diseases 2012;12(12):966-76.
2012: Katherine Gibney; Olga I Kosoy; Robert S Lanciotti; Mark MULLIGAN; Amanda J Panella; Mark J Delorey; Srilatha Edupuganti; Marc Fischer; J Erin Staples
Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.
The American journal of tropical medicine and hygiene 2012;87(6):1112-5.
2012: Lisa A Jackson; Harry L Keyserling; Karen L Kotloff; Mark MULLIGAN; Diana L Noah; Nadine Rouphael; Jack T Stapleton; Anna Wald; Patricia L Winokur; Rebecca C Brady; Wilbur H Chen; Cornelia L Dekker; Srilatha Edupuganti; Heather Hill; Mark C Wolff
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.
The Journal of infectious diseases 2012;206(6):811-20.
2012: Gui-Mei Li; Megan McCausland; Aneesh K Mehta; Mark MULLIGAN; Xinyan Qu; Patrick C Wilson; Jens Wrammert; Jonathan W Yewdell; Nai-Ying Zheng; Sarah F Andrews; Christopher Chiu; Suman Das; Srilatha Edupuganti; Min Huang; Jane-Hwei Lee; Rafi Ahmed
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(23):9047-52.
2011: Srilatha Edupuganti; Nadine Rouphael; Aneesh Mehta; Molly EATON; John G Heller; Adam M Bressler; Mary Brandt; Kerry O'Donnell
Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification.
Journal of clinical microbiology 2011;49(6):2350-3.
2011: Robert B Belshe; Sharon E Frey; Irene Graham; Mark MULLIGAN; Srilatha Edupuganti; Lisa A Jackson; Anna Wald; Gregory Poland; Robert Jacobson; Harry Keyserling; Paul Spearman; Heather Hill; Mark Wolff
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
The Journal of infectious diseases 2011;203(5):666-73.
2011: Jens Wrammert; Dimitrios Koutsonanos; Gui-Mei Li; Srilatha Edupuganti; Jianhua Sui; Michael Morrissey; Megan McCausland; Ioanna Skountzou; Mady Hornig; W Ian Lipkin; Aneesh Mehta; Behzad Razavi; Carlos Del Rio; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Zahida Ali; Kaval Kaur; Sarah Andrews; Rama Rao Amara; Youliang Wang; Suman Das; Christopher David O'Donnell; Jon W Yewdell; Kanta Subbarao; Wayne A Marasco; Mark MULLIGAN; Richard W Compans; Rafi Ahmed; Patrick C Wilson
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.
The Journal of experimental medicine 2011;208(1):181-93.
2009: Rama S Akondy; Nathan D Monson; Joseph D Miller; Srilatha Edupuganti; Dirk Teuwen; Hong Wu; Farah Quyyumi; Seema Garg; John D Altman; Carlos Del Rio; Harry L Keyserling; Alexander Ploss; Charles M Rice; Walter A Orenstein; Mark MULLIGAN; Rafi Ahmed
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(12):7919-30.
2009: Jennifer A Whitaker; carlos franco-paredes; Carlos del Rio; Srilatha Edupuganti
Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas.
Journal of travel medicine 2009;16(1):46-52.
2009: Clayton D Harro; Michael N Robertson; Michelle A Lally; Lori D O'Neill; Srilatha Edupuganti; Paul A Goepfert; Mark MULLIGAN; Frances H Priddy; Sheri A Dubey; Lisa S Kierstead; Xiao Sun; Danilo R Casimiro; Mark J DiNubile; John W Shiver; Randi Y Leavitt; Devan V Mehrotra
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.
AIDS research and human retroviruses 2009;25(1):103-14.
2008: Joseph D Miller; Robbert van der Most; Rama S Akondy; John T Glidewell; Sophia Albott; David Masopust; Kaja Murali-Krishna; Patryce L Mahar; Srilatha Edupuganti; Susan Lalor; Stephanie Germon; Carlos del Rio; Mark MULLIGAN; Silvija I Staprans; John D Altman; Mark B Feinberg; Rafi Ahmed
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
Immunity 2008;28(5):710-22.
2004: Srilatha Edupuganti; David J Weber; Charles Poole
Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies.
HIV clinical trials 2004;5(5):259-68.
1998: JS Swartley; LJ Liu; Yoon K Miller; Larry E Martin; Srilatha Edupuganti; David S Stephens
Characterization of the gene cassette required for biosynthesis of the (alpha1-->6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis.
Journal of bacteriology 1998;180(6):1533-9.
1997: Srilatha Edupuganti; Frank Svec; W Bao; S R Srinivasan; G S Berenson
Thyroid function in children with different lipoprotein profiles: observations in a biracial (black/white) population--the Bogalusa Heart Study.
The American journal of the medical sciences 1997;313(2):80-4.
1997: JS Swartley; A A Marfin; Srilatha Edupuganti; LJ Liu; Paul R Cieslak; B Perkins; Jay Wenger; David S Stephens
Capsule switching of Neisseria meningitidis.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(1):271-6.